Pharmaceuticals and Biotech Press Releases

Johns Hopkins OpenSpecimen Adoption Over the Years

Johns Hopkins OpenSpecimen Adoption Over the Years

Current Adoption Status: 67 collection protocols / 40+ active usersPublished 67 peer-reviewed articlesSupported 20 grantsManages 400K specimens for 40K study participants100+K specimens sent to Precision Medicine platform*Reference: 2019 OpenSpecimen JHU Annual ReportThe Johns Hopkins University School of Medicine adopted OpenSpecimen…

Climet Announces Introduction of the CI-97 Microbial Air Sampler With Data Integrity and New Advanced Features

Climet Announces Introduction of the CI-97 Microbial Air Sampler With Data Integrity and New Advanced Features

Climet Instruments Company, a Division of Venturedyne Ltd, (herein 'Climet') the leading manufacturer of high quality cleanroom particle counters and microbial samplers, today announced the introduction of their CI-97 microbial air sampler.Climet Instruments Company is very proud to announce the introduction of the…

Jubilant Radiopharma and Cylcomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the International Conference on Nuclear Cardiology

Jubilant Radiopharma and Cylcomedica Europe Announce Their Partnership for the Distribution of RUBY-FILL® During the International Conference on Nuclear Cardiology

Jubilant Radiopharma, a business division of Jubilant Pharma Limited, and Cyclomedica Europe Ltd, a wholly owned subsidiary of Cyclopharm Limited, will announce their partnership at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC), taking place on May 9-11,…

EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle

EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle

EW Healthcare Partners ("EW") has acquired a majority stake in Laboratoires Majorelle ("Majorelle") from its Founders to support its growth and European expansion in line with the Founders' strategy.Headquartered in Paris, Majorelle is a French specialty pharma company focused on…

Nemysis Ltd Announces Appointment of Dr. Margit Holzer to Its Scientific Advisory Board

Nemysis Ltd Announces Appointment of Dr. Margit Holzer to Its Scientific Advisory Board

Nemysis Ltd announced today the appointment of Dr. Margit Holzer to its Scientific Advisory Board (SAB).Dr. Margit Holzer, Scientific Director at Ulysse-Consult Sarl, is a passionate biochemical engineer with internationally recognized expertise in development, industrialization and implementation of biotechnological production processes,…

WholisticResearch Acquires Domain of Adherex Technologies Inc.

WholisticResearch Acquires Domain of Adherex Technologies Inc.

WholisticResearch, the fact-finding blog on rare nootropics and peptides, announced today that it had acquired the domain name previously owned by Adherex Technologies Inc. biopharmaceutical company, committed to discover and develop therapeutics for cancer and cognitive improvement.The CEO of WholisticResearch shared, "I…

GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals

GEN inCode Announces Major UK Collaboration With Royal Brompton and Harefield Hospitals

GEN inCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and Harefield hospitals ("RB&H"), recently merged with Guy's and St Thomas' NHS Foundation Trust ("GSTT"),…

Glauconix Data Published in Prestigious Ophthalmology Journal as Part of Their Work With NCX 667, a Novel Nitric Oxide Donor Agent With Intraocular Pressure Lowering Ability

Glauconix Data Published in Prestigious Ophthalmology Journal as Part of Their Work With NCX 667, a Novel Nitric Oxide Donor Agent With Intraocular Pressure Lowering Ability

Glauconix Biosciences, Inc., leading developer of human 3D ocular tissues, and Nicox SA co-authored, a manuscript in Investigative Ophthalmology and Visual Sciences, demonstrating the IOP lowering ability of NCX 667, a novel nitric oxide donor. These studies were performed using…

GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel

GeneTex Launches SARS-CoV-2 Variant Spike RBD ACE2 Binding Activity-Neutralization Assay Panel

GeneTex, a leading international research antibody manufacturer, continues to expand and diversify its nearly comprehensive portfolio of SARS-CoV-2/COVID-19 reagents. Recently, the company has focused on developing products to help overcome the viral variants that threaten to undermine the social distancing…

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert Linda Cavaletti

Nemysis Ltd Strengthens Its Scientific Advisory Board With Nutritional and Pharmaceutical Solutions Expert Linda Cavaletti

Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB).Since its inception, Nemysis has initiated and developed high-value innovative R&D programs, including one targeting Celiac Disease and Non-Celiac…

eDeviation the New Protocol Deviations Cloud Software Solution

eDeviation the New Protocol Deviations Cloud Software Solution

Ethical GmbH, the Swiss company providing personalized software solutions for clinical research committees management, has developed a new software solution designed to simplify the protocol deviation (PD) assessment and management process.The new eDeviation®solution will allow clinical trial sponsors, CROs, and EC/IRB…

BenchSci Ranks 26 on the 2021 List of 50 Best Workplaces in Canada

BenchSci Ranks 26 on the 2021 List of 50 Best Workplaces in Canada

BenchSci has been ranked 26 of the 50 Best Workplaces™ in Canada and certified a Great Place to Work® for the second consecutive year. The certification follows a thorough and independent analysis of hundreds of Canadian companies by Great Place…

Philogen Announces Publication of Best-in-Class FAP-Targeting Small Molecule Ligand (OncoFAP) in PNAS

Philogen Announces Publication of Best-in-Class FAP-Targeting Small Molecule Ligand (OncoFAP) in PNAS

Philogen S.p.A., a listed clinical-stage biotechnology company focused on the development of innovative medicines based on tumor targeting antibodies and small molecule ligands, is pleased to announce a publication describing the development and the in vivo characterization of OncoFAP, a…

Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry

Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry

Philogen S.p.A., a listed clinical-stage biotechnology company focused on the development of innovative medicines based on tumor-targeting antibodies and small molecule ligands, is pleased to announce a publication describing the construction of a DNA-encoded chemical library (DEL) that was successfully…

Compliance Group Inc. Digitalizes Lifesciences Quality Management Systems With iQuality E-QMS Suite of Products

Compliance Group Inc. Digitalizes Lifesciences Quality Management Systems With iQuality E-QMS Suite of Products

iQMS, Software as a Service (SaaS) hosted on SOC 2 Type II and ISO 27001 certified iQuality Cloud, enables Life Sciences companies to improve product quality by leveraging the latest advancements in Artificial Intelligence and digitalizing the entire process for customers. This product suite provides…

Foundation for USP7 Related Diseases Announces Grant to Neurolentech in Search for Cure to Rare Disease Hao-Fountain Syndrome

Foundation for USP7 Related Diseases Announces Grant to Neurolentech in Search for Cure to Rare Disease Hao-Fountain Syndrome

The Foundation for USP7 Related Diseases (usp7.org) today announced a new research grant award to Neurolentech in a search for a cure to the rare disease Hao-Fountain Syndrome.The Austrian startup Neurolentech, led by Carsten Pfeffer, Ph.D. and co-founded by Gaia Novarino,…

Hardy Diagnostics Releases New Mass Spectrometer for Use in Non-Clinical Applications

Hardy Diagnostics Releases New Mass Spectrometer for Use in Non-Clinical Applications

Hardy Diagnostics, in collaboration with Autobio™, recently launched the Hardy Diagnostics Matrix-Assisted Laser Desorption/Ionized Time of Flight instrument, otherwise known as MALDI-TOF. The Autof MS 1000 provides high-speed identification and taxonomical classification of bacteria, yeasts, and filamentous fungi based on…

Valkyrie Group Places Big Bet With Hair Growth Pharmaceutical Firm Aneira Pharma, Inc.

Valkyrie Group Places Big Bet With Hair Growth Pharmaceutical Firm Aneira Pharma, Inc.

Investment and growth firm Valkyrie Group ("Valkyrie") has committed an investment of $25 million into Aneira Pharma, Inc. ("Aneira") to be used toward completion of its clinical trials. Aneira is developing a ground-breaking, prescription-based hair growth product for men and…

Americans Left in Limbo Over Lower Drug Costs

Americans Left in Limbo Over Lower Drug Costs

American families are still waiting for government help to lower the cost of medications. Two months into the new administration, President Joe Biden delivered his first solo press conference without addressing spiraling medication costs. Until there is coordinated relief for…

VMS BioMarketing Names Tom Fagan as Chief Operating Officer

VMS BioMarketing Names Tom Fagan as Chief Operating Officer

VMS BioMarketing - a leading provider of nurse-led patient and HCP engagement solutions for the biopharma industry - announced today that Thomas D. Fagan, Jr. has joined the company as Chief Operating Officer."Tom joins us at a time when we…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login